[Hormonal treatment of cancer of the prostate: review and present status].
Ganzer
R
R
Klinik und Poliklinik für Urologie, Universität Regensburg, Krankenhaus St Josef.
Wieland
W F
WF
Bach
T
T
Rössler
W
W
Blana
A
A
D000284:Administration, Oral; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000813:Anilides / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D016001:Confidence Intervals; D017373:Cyproterone Acetate / Q000008:administration & dosage / Q000627:therapeutic use; D004195:Disease Models, Animal; D004285:Dogs; D004967:Estrogens / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D008297:Male; D015201:Meta-Analysis as Topic; D015337:Multicenter Studies as Topic; D009570:Nitriles; D009919:Orchiectomy; D011446:Prospective Studies; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology / Q000601:surgery; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D013739:Testosterone / Q000097:blood / Q000502:physiology; D013997:Time Factors; D014105:Tosyl Compounds
D000726:Androgen Antagonists; D000813:Anilides; D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D004967:Estrogens; D009570:Nitriles; D014105:Tosyl Compounds; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D017373:Cyproterone Acetate; C053541:bicalutamide